Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0319 Transporter Info | ||||
Gene Name | SLC36A2 | ||||
Transporter Name | Proton-coupled amino acid transporter 2 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Mycotoxins |
|||||
Aflatoxin B1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 results in increased methylation of SLC36A2 intron | [3] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
aflatoxin B2 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
aflatoxin B2 results in decreased methylation of SLC36A2 intron | [3] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Chemical Compound |
|||||
DT Modulation1 |
Cisplatin co-treated with jinfukang results in increased expression of SLC36A2 mRNA | [1] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Benzo(a)pyrene |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene affects the methylation of SLC36A2 intron | [3] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Benzo(a)pyrene affects the methylation of SLC36A2 promoter | [4] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Benzo(a)pyrene results in increased methylation of SLC36A2 3' UTR | [4] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
benzo(e)pyrene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
benzo(e)pyrene results in decreased methylation of SLC36A2 intron | [3] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
ferrous chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
ferrous chloride results in increased expression of SLC36A2 mRNA | [5] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Methapyrilene |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Methapyrilene results in decreased methylation of SLC36A2 intron | [3] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Cisplatin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cisplatin increases the expression of SLC36A2 | [1] | |||
Discontinued Drug |
|||||
NOX-200 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NOX-200 inhibits the activity of SLC36A2 | [2] | |||
Investigative Drug |
|||||
5-Hydroxy-L-tryptophan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
5-Hydroxy-L-tryptophan inhibits the activity of SLC36A2 | [2] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.